TY - JOUR
T1 - Oral health-related quality of life in children and adolescents with osteogenesis imperfecta
T2 - Cross-sectional study
AU - Najirad, Mohammadamin
AU - Ma, Mang Shin
AU - Rauch, Frank
AU - Sutton, Vernon Reid
AU - Lee, Brendan
AU - Retrouvey, Jean Marc
AU - Nagamani, Sandesh C.S.
AU - Glorieux, Francis
AU - Esposito, Paul
AU - Rush, Eric
AU - Bober, Michael
AU - Eyre, David
AU - Gomez, Danielle
AU - Harris, Gerald
AU - Hart, Tracy
AU - Jain, Mahim
AU - Krakow, Deborah
AU - Krischer, Jeffrey
AU - Orwoll, Eric
AU - Raggio, Cathleen
AU - Smith, Peter
AU - Tosi, Laura
AU - Esfandiari, Shahrokh
N1 - Publisher Copyright:
© 2018 The Author(s).
PY - 2018/10/25
Y1 - 2018/10/25
N2 - Background: Osteogenesis imperfecta (OI) affects dental and craniofacial development and may therefore impair Oral Health-Related Quality of Life (OHRQoL). However, little is known about OHRQoL in children and adolescents with OI. The aim of this study was to explore the influence of OI severity on oral health-related quality of life in children and adolescents. Methods: Children and adolescents aged 8-14 years were recruited in the context of a multicenter longitudinal study (Brittle Bone Disease Consortium) that enrolls individuals with OI in 10 centers across North America. OHRQoL was assessed using the Child Perceptions Questionnaire (CPQ) versions for 8 to 10-year-olds (CPQ 8-10 ) and for 11 to 14-year-olds (CPQ 11-14 ). Results: A total of 138 children and adolescents (62% girls) diagnosed with OI types I, III, IV, V and VI (n = 65, 30, 37, 4 and 2, respectively) participated in the study. CPQ 8-10 scores were similar between OI types in children aged 8 to 10 years. In the 11 to 14-year-old group, CPQ 11-14 -scores were significantly higher (i.e. worse) for OI types III (24.7 [SD 12.5]) and IV (23.1 [SD 14.8]) than for OI type I (16.5 [SD 12.8]) (P < 0.05). The difference between OI types was due to the association between OI types and the functional limitations domain, as OI types III and IV were associated with significantly higher grade of functional limitations compared to OI type I. Conclusion: The severity of OI impacts OHRQoL in adolescents aged 11 to 14 years, but not in children age 8 to 10 years.
AB - Background: Osteogenesis imperfecta (OI) affects dental and craniofacial development and may therefore impair Oral Health-Related Quality of Life (OHRQoL). However, little is known about OHRQoL in children and adolescents with OI. The aim of this study was to explore the influence of OI severity on oral health-related quality of life in children and adolescents. Methods: Children and adolescents aged 8-14 years were recruited in the context of a multicenter longitudinal study (Brittle Bone Disease Consortium) that enrolls individuals with OI in 10 centers across North America. OHRQoL was assessed using the Child Perceptions Questionnaire (CPQ) versions for 8 to 10-year-olds (CPQ 8-10 ) and for 11 to 14-year-olds (CPQ 11-14 ). Results: A total of 138 children and adolescents (62% girls) diagnosed with OI types I, III, IV, V and VI (n = 65, 30, 37, 4 and 2, respectively) participated in the study. CPQ 8-10 scores were similar between OI types in children aged 8 to 10 years. In the 11 to 14-year-old group, CPQ 11-14 -scores were significantly higher (i.e. worse) for OI types III (24.7 [SD 12.5]) and IV (23.1 [SD 14.8]) than for OI type I (16.5 [SD 12.8]) (P < 0.05). The difference between OI types was due to the association between OI types and the functional limitations domain, as OI types III and IV were associated with significantly higher grade of functional limitations compared to OI type I. Conclusion: The severity of OI impacts OHRQoL in adolescents aged 11 to 14 years, but not in children age 8 to 10 years.
KW - Child perceptions questionnaires
KW - Oral health-related quality of life
KW - Osteogenesis imperfecta
UR - http://www.scopus.com/inward/record.url?scp=85055618264&partnerID=8YFLogxK
UR - http://www.scopus.com/inward/citedby.url?scp=85055618264&partnerID=8YFLogxK
U2 - 10.1186/s13023-018-0935-y
DO - 10.1186/s13023-018-0935-y
M3 - Article
C2 - 30359278
AN - SCOPUS:85055618264
SN - 1750-1172
VL - 13
JO - Orphanet Journal of Rare Diseases
JF - Orphanet Journal of Rare Diseases
IS - 1
M1 - 187
ER -